<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="157089">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01054664</url>
  </required_header>
  <id_info>
    <org_study_id>nephrop003</org_study_id>
    <nct_id>NCT01054664</nct_id>
  </id_info>
  <brief_title>The Incidence of Occult Hepatitis C Virus Infection in Hemodialysed Patients With Liver Enzymes Disturbances</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <brief_summary>
    <textblock>
      To assess the incidence of occult hepatitis C virus in hemodialysed patients with mild
      impairment of liver enzymes
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      occult hepatitis C virus will be checked in monocytes of hemodialyzed patients with
      permanent mild impairment of liver enzymes This population has no evidence of hepatitis B or
      C according to standard laboratory tests (HVC antibodies,HCV PCR, hepatitis B antibodies)
      Hepatitis C virus RNA will be performed in peripheral blood mononuclear cells of
      hemodialysed patients
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2010</start_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hemodialysed Patients With Impaired Liver Enzymes</condition>
  <arm_group>
    <arm_group_label>impaired liver enzymes</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>normal liver enzymes</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>hepatitis C antibodies positive</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        hemodialysis patients with impaired liver enzymes
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hemodialysed patients with impaired liver enzymes

        Exclusion Criteria:

          -  hepatitis B and C positive
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eleonora Plotkin, MD</last_name>
    <phone>972 9 7472517</phone>
    <email>nora.plotkin@clalit.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Plotkin Eleonora</name>
      <address>
        <city>Kfar Saba</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Osnat Klein, MD</last_name>
      <phone>972 9 7472517</phone>
      <email>Klein.Osnat@clalit.org.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <lastchanged_date>January 21, 2010</lastchanged_date>
  <firstreceived_date>January 21, 2010</firstreceived_date>
  <responsible_party>
    <name_title>Plotkin Eleonora</name_title>
    <organization>Clalit Health services</organization>
  </responsible_party>
  <keyword>liver enzymes</keyword>
  <keyword>peripheral mononuclear blood cells</keyword>
  <keyword>hemodialysis</keyword>
  <keyword>hepatitis C</keyword>
  <keyword>RNA</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
